View Older Stories View More Recent Stories

May 2, 2014 06:55AM Roth Capital Upgrades Maxwell Technologies (MXWL) to Buy
May 1, 2014 10:41AM Celldex (CLDX) Upcoming Clinical Data, Study Expansions, Pipeline Keep Roth Positive; 'Focus List' Rating Affirmed
May 1, 2014 10:14AM Roth Comments on Palatin's (PTN) BMT Agreement with European Partner; Reaffirms 'Buy' Rating
Apr 30, 2014 03:22PM Viggle, Inc. (VGGL) Closes 4.38M Common Offering for Gross Proceeds of $35M
Apr 30, 2014 02:48PM Roth Positive on Cytokinetics (CYTK) Following BENEFIT-ALS Update; Several Points Go in Tirasemtiv's Favor
Apr 30, 2014 10:00AM Roth Affirms Ligand (LGND) at Buy; FDA Grants Promacta/Revolade Priority Review
Apr 30, 2014 07:51AM Roth Capital Upgrades Trinity Biotech (TRIB) to Buy
Apr 29, 2014 10:16AM New BENEFIT-ALS Data from Cytokinetics (CYTK) is 'Exciting'; Investors Should Regain Confidence - Roth
Apr 29, 2014 08:45AM Roth Capital Downgrades Ultra Clean (UCTT) to Neutral
Apr 28, 2014 10:09AM DoD Supporting Galena's (GALE) NeuVax Provides Important Third-Party Scientific Validation - Roth
Apr 25, 2014 12:28PM Viggle, Inc. (VGGL) NASDAQ Uplisting/IPO Opens Lower
Apr 25, 2014 09:35AM Roth Slashes PT on Cytokinetics (CYTK) to $13; ALS Call Missed, but Omecamtiv Provides Buffer
Apr 25, 2014 08:47AM Viggle, Inc. (VGGL) Prices Larger 4.38M Common Offering at $8 Apiece
Apr 24, 2014 10:28AM Zerenex Costs Savings, Differentiation Highlighted; PDUFA Date Still in Focus (KERX) - Roth Capital
Apr 23, 2014 09:56AM Roth 'Encouraged' to See Bavituximab Moving Forward; Affirms Peregrine Pharma (PPHM) at 'Buy'
Apr 22, 2014 09:43AM Roth Capital Pounds Table on Cytokinetics (CYTK) into AAN BENEFIT-ALS Presentation
Apr 22, 2014 06:37AM Roth Capital Starts GSV Capital (GSVC) at Buy
Apr 21, 2014 10:40AM Notable Analyst Rating Changes 04/21: (MS) (AWI) (HNI) Upgraded; (WLT) (MGI) (YUM) Downgraded
Apr 21, 2014 09:15AM Roth Capital Starts Applied Genetic Tech (AGTC) at Buy; Catalysts in 2015 Add Appeal
Apr 17, 2014 10:19AM Roth Affirms Clean Diesel (CDTI) at 'Buy'; Sees L-T, Catalyst-Focused Strategy Playing Out
Apr 16, 2014 08:55AM xG Technology (XGTI) Prices 5.27M Common Offering at $1.90/Share
Apr 14, 2014 03:00PM Low European Exposure Boosts JA Solar (JASO) in Q1 - Analyst
Apr 14, 2014 01:34PM Roth Affirms Bullish Position on Retrophin (RTRX) Following Financial, Pipeline Updates
Apr 14, 2014 08:11AM Roth Capital Starts AcelRx Pharmaceuticals (ACRX) at Buy
Apr 14, 2014 06:52AM Roth Capital Upgrades PriceSmart (PSMT) to Buy
Apr 14, 2014 06:39AM Trina Solar (TSL) Follows Suit in Q1 as Europe Lowers Floor Price; Roth Maintains at 'Buy'
Apr 11, 2014 10:32AM Mixed Prelim. Q1 Numbers from Yingli Green Energy (YGE) Keep Roth at 'Neutral'
Apr 11, 2014 08:33AM NTN Buzztime (NTN) Prices 11.1M Offering at 55c/Share
Apr 11, 2014 07:59AM Roth Capital Starts Flamel Technologies (FLML) at Buy
Apr 8, 2014 02:05PM Roth Boosts PT on Sunesis Pharma (SNSS) to $15; Focus Remains on Vosaroxin
Apr 8, 2014 11:00AM PlacementTracker Publishes First Quarter 2014 PIPE Market League Tables
Apr 8, 2014 10:30AM Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering
Apr 8, 2014 09:32AM Pharmacyclics' (PCYC) IMBRUVICA Should Get Full Approval Before End of 2014; Roth Keeps at 'Buy'
Apr 7, 2014 11:57AM Streetinsider.com's Hot Lunchtime Reads 04/07: (KR) (MSFT) (SRPT) (MDVN)
Apr 7, 2014 11:14AM Pre-Clinical Data for MEI Pharma's (MEIP) Pracinostat Will Set Development Tone - Roth Capital
Apr 7, 2014 11:01AM American Apparel (APP) Price Target Reduced to $0.75 at Roth
Apr 4, 2014 12:11PM Roth Affirms Hydrogenics (HYGS) at 'Bur'; Customer-Driven Hiccup Doesn't Affect Overall Thesis
Apr 4, 2014 08:34AM Ocean Power Technologies (OPTT) Prices 3.8M Offering at $3.10/sh
Apr 4, 2014 08:30AM Ocean Power Technologies Prices Underwritten Public Offering of Common Stock
Apr 4, 2014 08:12AM Roth Capital Starts Energy Fuels (UUUU) at Buy
Apr 4, 2014 07:17AM Roth Capital Starts Uranium Resources (URRE) at Buy
Apr 3, 2014 04:39PM Ocean Power Technologies, Inc. (OPTT) Plans Common Stock Offering
Apr 3, 2014 04:29PM Ocean Power Technologies Announces Proposed Public Offering of Common Stock
Apr 3, 2014 04:01PM SolarCity (SCTY) ABS Offerings are Evolutionary Step Toward Lower-Cost Financing - Roth
Apr 3, 2014 04:01PM AGTC Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Apr 3, 2014 09:02AM Catyalyst Pharma (CPRX) Prices 11.33M Common Offering at $2.21/Share
Apr 2, 2014 04:04PM Endocyte (ECYT) Closes 5.18M Offering; Sees Net Proceeds of $101.8M
Apr 2, 2014 04:01PM Endocyte, Inc. Closes Public Offering of Common Stock
Apr 2, 2014 08:45AM Roth Affirms Keryx (KERX) at 'Buy'; ESRD Overhang Removed
Apr 1, 2014 11:23AM Roth Lifts PT on Stemline (STML) to $62; Sees 'Pivotal' Year in 2014
View More Recent Stories View Older Stories